Lana A. Castellucci

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial”.

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

BMJ(2021)10.1136/bmj.n2400

N/A

5.3DataRank · unranked

371 citations

Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Fionnuala Ní Áinle +35 more

Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis

Journal of Thrombosis and Haemostasis(2023)10.1016/j.jtha.2023.03.004

N/A

1.1DataRank · unranked

46 citations

Ernest K. Amankwah, Marisol Betensky, Lana A. Castellucci, Adam Cuker, Neil A. Goldenberg +5 more

Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19

JACC Advances(2024)10.1016/j.jacadv.2023.100780

N/A

0.292DataRank · unranked

6 citations

Matthew D. Neal, Ewan C. Goligher, Mary Cushman, Brett L. Houston, Charlotte Bradbury +35 more

Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial

Research and Practice in Thrombosis and Haemostasis(2023)10.1016/j.rpth.2023.102203

N/A

0.129DataRank · unranked

1 citations

Anna Heath, Matthew D. Neal, Ryan Zarychanski, Lucy Z. Kornblith, Beverley J. Hunt +5 more

Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial

Research and Practice in Thrombosis and Haemostasis(2023)10.1016/j.rpth.2023.102167

N/A

0DataRank · unranked

8 citations

Erinn M. Hade, Lucy Z. Kornblith, Lana A. Castellucci, Mary Cushman, Michael E. Farkouh +16 more

Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

Nature Reviews Cardiology(2024)10.1038/s41569-024-01003-3

N/A

0DataRank · unranked

20 citations

Parham Sadeghipour, Luis Ortega‐Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig J. Beavers +31 more

A comparison of computational algorithms for the Bayesian analysis of clinical trials

Clinical Trials(2024)10.1177/17407745241247334

N/A

0DataRank · unranked

8 citations

Jeffrey S. Berger, Lana A. Castellucci, Michael E. Farkouh, Ewan C. Goligher, Erinn M. Hade +9 more

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

Bristol Research (University of Bristol)(2021)10.17863/cam.76384

N/A

0DataRank · unranked

589 citations

ACTIV-4a Investigators, REMAP-CAP Investigators, Matthew D. Neal, Bryan J. McVerry, José Carlos Nicolau +94 more